The core idea
A protocol is a chain of coordinated decisions
CTCA succeeds only when anatomy, motion control, scan range, contrast arrival, exposure, and reconstruction all align during a very short acquisition. Optimising one variable in isolation can still produce a non-diagnostic study.
The planning sequence is: define the question → choose coverage and acquisition → calculate the bolus → synchronise injection and scan → rehearse → run a final pause. Patient preparation is Topic 03; ECG-gated acquisition is Topic 02. Here the focus is how those inputs become one coherent protocol.
Before the patient enters the gantry
Make the room and system injection-ready
Dr Tosha begins after the patient has been assessed and prepared. Confirm that the contrast injector, saline, tubing, monitoring, ECG interface, and emergency equipment are functional before positioning. Use warmed modern nonionic iodinated contrast when the departmental protocol calls for it; warming reduces viscosity and can make high-rate delivery easier. Verify the contrast identity, concentration, expiry, volume, route, programmed phases, pressure limit, and patient.
- Access: a tested, secure, power-injection-safe IV appropriate to the intended rate; adult CTCA commonly uses 18–20 G antecubital access.
- Laterality: right antecubital access may reduce dense contrast in the left brachiocephalic vein/SVC, but a safe, reliable left-sided line is preferable to a poor right-sided line.
- Flow: 5–7 mL/s is a common adult teaching range, not a universal prescription. The catheter, vein, injector pressure, body habitus, kVp, iodine concentration, and scan duration all matter.
- Safety: observe the site when possible, maintain communication, and follow local reaction/extravasation procedures.
“Ionic” is not shorthand for a good CTCA agent. Contemporary intravascular CT generally uses nonionic low- or iso-osmolality iodinated contrast. What determines arterial delivery is the complete protocol—iodine concentration, flow, duration, timing, saline, patient physiology, and tube voltage.
Geometry first
Position the heart at isocentre and use the scout deliberately
Position supine with arms comfortably above the head when possible. Keep ECG electrodes, cables, and injection tubing outside the cardiac field without compromising signal or access. Centre the heart, not merely the external chest, at gantry isocentre; off-centring can impair automatic exposure selection, spatial resolution, and dose efficiency.
Acquire the localiser/scout required by the scanner—often AP and lateral. Use it to confirm centring, choose the displayed field of view, and plan the superior/inferior limits. The scout also informs automatic tube-current and kV tools, so poor centring or arms in the field can alter the exposure recommendation.
- Confirm a clean ECG with reliable R-wave detection during the rehearsed breath-hold.
- Run a dry table movement so shoulders, arms, lines, and injector tubing remain clear.
- Review the scout before accepting any automatically suggested scan box.
Noncontrast planning
Calcium scoring: preserve comparability when Agatston is the goal
A conventional coronary calcium scan is prospectively ECG-triggered and noncontrast, covering the heart from just below the carina through the cardiac apex. A small cardiac display field of view—often about 180–220 mm depending on patient size—is used for reconstruction.
| Element | Standard principle | Why it matters |
|---|---|---|
| Tube voltage | 120 kVp for conventional Agatston scoring. | The historical 130-HU threshold and outcome data were built around standard acquisition. Lower-kVp methods need a validated recalibration. |
| Slice thickness | Approximately 2.5–3.0 mm. | Changing thickness changes noise and measured calcium burden, reducing serial comparability. |
| Tube current | Adjust to patient size or use a validated automatic setting. | Too little current raises noise and false-positive pixels; excess current wastes dose. |
| ECG timing | Prospective triggering in a relatively motion-free phase. | Motion can fragment or blur calcification and change the score. |
Calcium scoring can reveal burden, help identify the first/last coronary levels, and inform whether CTCA is likely to be limited by blooming. It is not mandatory before every CTCA; because it adds radiation, its use should follow the clinical question and local protocol.
Thin, low-kVp, or AI-enabled calcium techniques may be useful, but an Agatston score should only be reported from a protocol validated for that purpose. Serial follow-up is most meaningful when acquisition and reconstruction remain consistent.
Coverage discipline
Define the smallest z-axis range that fully answers the question
For native coronary CTCA, typical coverage extends from around the tracheal bifurcation or mid left pulmonary artery through the cardiac apex—often roughly 12–15 cm, but anatomy varies. If a calcium scan is available, identify the first coronary-containing image (often left main/LAD level) and the last distal coronary level (including the PDA when relevant), then add a modest safety margin.
Too short a range can omit an ostium, distal vessel, or anomalous course. Too long a range increases radiation and contrast requirements and may prolong breath-hold. Review anatomy rather than blindly accepting a saved range.
Native coronary disease, anomalous origin, bypass grafts, transcatheter planning, triple rule-out, and congenital disease require different limits. Coverage must be set before calculating scan time and contrast duration.
Contrast mechanics
Think in iodine delivery, duration, and timing—not volume alone
Coronary enhancement depends on how much iodine reaches the arterial circulation per second and for how long. A compact planning model is:
Worked arithmetic: 350 mg I/mL at 5 mL/s delivers 1,750 mg I/s (1.75 g I/s). A 12-second contrast phase uses 60 mL. This is mathematics, not a patient prescription: the chosen rate and duration still need to match body size, kVp, IV capability, scan duration, and local validation.
Higher concentration and higher flow can both raise iodine delivery rate. Lower kVp increases iodine attenuation and may permit a lower iodine load in suitable patients. Larger blood volume, high cardiac output, long coverage, or slow acquisition can require a different strategy. The goal is homogeneous coronary/aortic opacification throughout the scan—not simply the highest possible HU.
Shape the bolus
Biphasic and triphasic injections serve different purposes
| Pattern | Sequence | Typical purpose |
|---|---|---|
| Biphasic | Undiluted contrast → saline chaser. | Efficient left-heart/coronary opacification with reduced residual dense contrast in peripheral tubing and central veins. |
| Triphasic | Undiluted contrast → contrast/saline blend → saline. | Softens the transition and can retain more right-heart/pulmonary enhancement when both sides of the circulation matter. |
The saline chaser pushes contrast remaining in the tubing and arm veins into the central circulation, narrows the trailing edge, reduces SVC/right-heart streak, and can reduce total contrast needed. Match its flow to the contrast phase when the access and protocol permit.
A triphasic blend is useful only when its proportions and timing are designed for the indication. It is not automatically superior for routine coronary-only imaging. Triple rule-out demands simultaneous diagnostic enhancement of the coronary/aortic and pulmonary circulations and therefore needs a specifically validated protocol.
Timing option 1
Bolus tracking: let arterial enhancement trigger the scan
- Place the monitoring ROI centrally in the ascending aorta, commonly below the carina, avoiding the wall, calcification, motion, and adjacent SVC.
- Begin low-dose monitoring after an initial delay appropriate to the injection site and expected transit.
- Use the scanner/local threshold—commonly in the range of 100–150 HU above baseline or an equivalent absolute threshold.
- Account for the system’s fixed time from threshold detection to diagnostic acquisition: instruction, breath-hold, table movement, and scanner preparation.
The ROI threshold is a trigger, not the desired final coronary attenuation. Enhancement continues to rise during the built-in post-trigger delay. Threshold and delay are scanner- and protocol-specific; importing values from another platform can make the scan too early or too late.
A misplaced ROI, motion, shallow IV injection, unexpected collateral flow, or severe low output can produce an abnormal curve. If the trigger behaves implausibly, pause when still possible and check the patient, IV, and ROI rather than assuming the diagnostic scan will rescue itself.
Timing option 2
Test bolus: measure the patient’s transit before the main injection
A small contrast bolus—commonly about 10–20 mL—followed by saline is injected at the intended diagnostic flow. Repeated low-dose images at the ascending-aortic ROI generate a time–attenuation curve. The diagnostic delay is based on measured time to peak plus the scanner/protocol margin, often about 2–4 seconds.
Advantages: direct information about individual transit and enhancement shape; useful when haemodynamics are uncertain. Costs: extra contrast, monitoring radiation, setup, and one more breath-hold. Bolus tracking is faster and automatically responsive, but depends on correct ROI and threshold behaviour. Neither method is universally best.
The test bolus should use the same IV, planned flow, and a comparable saline chase. Changing access, rate, or breathing between test and diagnostic phases weakens the transit estimate.
Synchronise the moving heart
Choose acquisition before finalising contrast duration
Prospective axial, high-pitch spiral, and retrospectively gated helical modes have different scan times, phase coverage, rhythm tolerance, and dose. Topic 02 covers their selection in detail; the protocol-planning point is that scan duration drives bolus duration.
- Stable low rate: a narrow prospective window or high-pitch mode may enable short acquisition and lower dose on suitable scanners.
- Higher/variable rate or functional need: a wider prospective window or retrospective mode may be needed, with greater dose and longer contrast coverage.
- Arrhythmia: use scanner-specific arrhythmia handling and decide whether the expected diagnostic value remains acceptable.
- Direction: cranio-caudal versus caudo-cranial scanning is protocol/scanner dependent; it is not a universal rule.
Before injection, verify heart-rate assumptions against the live ECG and the rehearsed breath-hold. A protocol selected from an earlier resting pulse may no longer fit.
Patient-specific protocol
Adapt exposure and contrast as a coordinated pair
| Patient factor | Likely effect | Planning response |
|---|---|---|
| Small body size | Less attenuation; iodine appears brighter at lower kVp. | Consider validated lower-kVp/automatic exposure protocol and adapt iodine load—avoid unnecessary mA or contrast. |
| Large body size | More photon starvation/noise and greater dilution volume. | Use automatic tube current/kV or validated higher settings; ensure adequate iodine delivery and IV capability without exceeding safe limits. |
| Low cardiac output | Delayed transit and broader/prolonged enhancement. | Expect later trigger/peak; bolus tracking or test bolus can personalise timing. Do not simply copy a fixed delay. |
| High cardiac output | Earlier transit and greater dilution. | Expect an earlier, sometimes narrower peak; optimise iodine delivery and timing. |
| Poor IV access | Cannot safely deliver the intended rate. | Secure appropriate access or redesign/reconsider the study; never force a high-flow protocol through unsuitable access. |
| Limited breath-hold | Motion risk increases with long acquisition. | Rehearse, use the shortest suitable mode/coverage, and ensure the bolus is timed to that actual acquisition. |
Automatic exposure tools assist but do not replace review. Confirm the proposed kVp/mA, scan length, rotation time, collimation, and dose estimate are appropriate for the patient and indication.
Question-specific coverage
Native coronaries, bypass grafts, and triple rule-out are not the same scan
Native coronary CTCA
Use tight cardiac coverage and left-heart-focused enhancement. Minimise range while including coronary origins and distal branches needed for the question.
Post-CABG assessment
Coverage is usually longer: include all known/probable proximal graft origins—potentially from the subclavian/internal mammary origin and ascending aorta—through the distal coronary anastomoses. Review the operative history if available. Longer range increases scan time, dose, and contrast-duration needs. Native coronaries may still require motion-optimised ECG gating.
Triple rule-out
This broad chest protocol attempts to assess coronary arteries, aorta, and pulmonary arteries. It requires wider z-axis coverage and carefully balanced contrast, commonly with a triphasic strategy. Dose and contrast burden are higher than focused CTCA; use it only for an appropriate clinical question and a validated local protocol.
A broader scan is not automatically safer or more complete. It can reduce coronary quality, increase dose/contrast, and still fail if the bolus was not designed for the additional vascular territory.
Dose without losing the answer
Optimise every contributor; avoid fixed dose promises
- Justify the study and choose the narrowest coverage that answers the question.
- Use prospective or high-pitch acquisition when rhythm, scanner, and clinical needs permit.
- Tailor kVp and tube current to patient size; use ECG-based tube-current modulation for retrospective scans when suitable.
- Optimise centring and field of view; use validated iterative/deep-learning reconstruction where available.
- Limit monitoring images and avoid unnecessary repeat scouts, calcium scans, or test boluses.
- Review CTDIvol and DLP against local diagnostic reference levels and investigate outliers.
Do not memorise one mSv value or percentage reduction as universal. Dose depends on scanner generation, patient size, scan length, mode, heart rate, phase window, and conversion assumptions. The correct target is the lowest dose that retains diagnostic quality for this patient and question.
The point of no return
Know what can be changed later—and what cannot
| Mostly locked at acquisition | Often adjustable in reconstruction/post-processing |
|---|---|
| Missing z-axis anatomy; mistimed or inadequate contrast; gross motion; failed ECG trigger; kVp/mAs; rotation time; collimation; selected gating mode and acquired phases. | Reconstruction phase if acquired; slice thickness/increment within raw-data limits; kernel; iterative strength; display FOV; window/level; MPR/curved MPR/3D presentation. |
This distinction explains the pre-scan pause. Reconstruction can improve noise, phase choice, and presentation; it cannot create omitted anatomy, restore a missed contrast peak, or fully undo severe motion. Topic 05 will cover reconstruction and post-processing in depth.
Operational sequence
The complete CTCA run-of-show
- Confirm the question: native coronaries, grafts, anomaly, triple rule-out, or another indication.
- Review patient constraints: size, rhythm, cardiac output, breath-hold, IV access, contrast safety, and medications.
- Prepare: room, ECG, injector, contrast/saline, monitoring, emergency readiness.
- Position: heart at isocentre, arms/lines clear, clean R-wave trace; rehearse the exact breath-hold.
- Scout: verify centring and planned anatomy; never accept auto-range blindly.
- Optional calcium scan: use a validated standard protocol when clinically indicated; review first/last coronary levels.
- Set CTCA range and mode: determine scan time and the ECG strategy.
- Design the bolus: iodine delivery, duration/volume, injection phases, saline, and timing method.
- Final pause: live rhythm, IV, ROI, threshold/delay, exposure, range, breath-hold, contrast and saline.
- Acquire and immediately inspect: coverage, enhancement, motion, ECG artefact, and technical adequacy before the patient leaves.
Apply the framework
Worked planning scenarios
Case A · 5 mL/s, planned 12-second contrast phase
The programmed contrast volume is 60 mL. If the agent is 350 mg I/mL, iodine delivery rate is 1.75 g I/s. Now verify that 12 seconds covers the actual scan and margin, the IV supports 5 mL/s, and the iodine load is appropriate for patient size, kVp, and local protocol.
Case B · Bolus-tracking ROI placed partly in the SVC
Dense venous contrast may trigger early, before the coronary arteries are adequately enhanced. Reposition the ROI centrally within the ascending aorta, away from wall/calcification/SVC, and recheck the local threshold and post-trigger delay.
Case C · Low-output patient with a fixed 18-second delay copied from another patient
Transit may be substantially delayed. Use bolus tracking or a test bolus when appropriate rather than guessing. A late-rising broad curve also changes how long the diagnostic bolus should be maintained.
Case D · Previous CABG but routine native-coronary scan box selected
The scan may omit proximal internal mammary or aortic graft origins. Confirm graft history, extend coverage to include relevant origins and distal anastomoses, recalculate scan time/contrast, and optimise ECG gating for the native/distal coronary targets.
Case E · Calcium scan at 100 kVp with conventional 130-HU Agatston threshold
Iodine is not involved, but calcium attenuation changes with kVp. Do not assume conventional Agatston equivalence. Use a validated recalibrated method or retain the standard 120-kVp/2.5–3-mm protocol for comparable scoring.
Active recall
Self-test: answer before opening each explanation
1. What three domains must every protocol coordinate?
The clinical question, the patient, and the scanner. Coverage and diagnostic target come from the question; physiology and safety from the patient; temporal resolution, scan duration, triggering, and dose tools from the scanner.
2. Why is conventional calcium scoring usually performed at 120 kVp and 2.5–3 mm?
Because the Agatston method’s 130-HU threshold and outcome evidence were developed with a standard acquisition. Changing kVp or thickness changes attenuation/noise and requires validated recalibration.
3. How do you calculate iodine delivery rate?
Iodine concentration (mg I/mL) × flow (mL/s). For 350 mg I/mL at 5 mL/s, the rate is 1,750 mg I/s or 1.75 g I/s.
4. How do you calculate contrast volume from a programmed phase?
Flow × duration. At 5 mL/s for 12 seconds, contrast volume is 60 mL. Clinical appropriateness still needs separate validation.
5. What does the saline chaser achieve?
It advances residual contrast from the tubing/arm veins, sharpens the bolus tail, can reduce total contrast, and reduces dense central venous/right-heart streak.
6. Where should a bolus-tracking ROI be placed?
Centrally in the ascending aorta—commonly below the carina—away from the wall, calcium, motion, and SVC. The threshold triggers a built-in delay; it is not the final target attenuation.
7. How is a diagnostic delay estimated with a test bolus?
Measure the ascending-aortic time to peak from a small bolus injected at the planned rate, then add the validated scanner/protocol margin, commonly around 2–4 seconds.
8. Why must scan mode be chosen before final contrast duration?
Prospective, high-pitch, and retrospective acquisitions have different scan times. The bolus must maintain adequate arterial enhancement for the entire actual acquisition.
9. What changes for post-CABG CTCA?
Coverage usually expands to include all graft origins through distal anastomoses, increasing scan time, dose, and bolus-duration needs. Operative information and ECG optimisation remain important.
10. Name three problems reconstruction cannot truly rescue.
Omitted anatomy, a missed/insufficient contrast bolus, and severe motion or failed ECG triggering. These acquisition decisions must be correct before or during the scan.
Printable quick revision
One-page protocol recall card
- Position: heart at isocentre; arms, leads, and tubing clear; verify AP/lateral scout.
- Calcium: conventional Agatston = 120 kVp, about 2.5–3 mm, ECG-triggered; preserve comparability.
- Range: smallest complete range; native coronary coverage is not graft or triple rule-out coverage.
- Iodine delivery: concentration × flow. Volume: flow × duration.
- Biphasic: contrast → saline. Triphasic: contrast → blend → saline.
- Tracking: central ascending-aortic ROI; threshold plus scanner’s post-trigger delay.
- Test bolus: small bolus at planned flow; time to peak plus validated margin.
- Tailor: size, kVp/mA, output, rhythm, IV, breath-hold, scanner and question.
- Dose: justify, shorten range/window, tailor exposure, review CTDIvol/DLP—no universal mSv promise.
Before injection, ask: Does the programmed bolus cover this exact acquisition, for this patient, over this anatomy?
Provenance
Sources and scope
This chapter follows the locally supplied Dr Tosha planning and protocol Webinar 1 talk (approximately 37½ minutes). Automated captions contain transcription errors, so scanner-specific numbers and broad claims were checked against professional guidance and framed as adaptable principles.
- SCCT Guidelines for the Performance and Acquisition of Coronary CT Angiography (2016) — coverage, injection, bolus tracking/test bolus, ECG acquisition, and dose.
- SCCT Guidelines on Radiation Dose and Dose-Optimisation Strategies in Cardiovascular CT — calcium scoring and coronary CTA dose principles.
- ASNC/AAPM/SCCT/SNMMI Guideline for Cardiac SPECT/CT and PET/CT (2022) — standard calcium-score acquisition parameters.
- CAR/CSTR Coronary CTA Practice Guidelines (2024) — contemporary acquisition and contrast principles.
- Contrast Enhancement in Cardiovascular CT (Radiographics, 2025) — iodine delivery, timing, saline, and patient factors.
Educational material only. Numeric examples are not injection prescriptions. Use manufacturer limitations, qualified supervision, and a validated local protocol for each scanner and patient. External references require internet; this chapter and self-test work offline.
Back to top ↑